Applied UV (AUVI) AI Stock Analysis

• Market Cap: $467.00
• Dividend Yield: N/A
• Average Volume (3M): 1.27K
• Price to Earnings (P/E): ―
• Beta (1Y): -0.93
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: US
• Employees: 131
• Sector: Consumer Cyclical
• Sector Strength: 84
• Industry: Furnishings, Fixtures & Appliances
• EPS (TTM): N/A
• Shares Outstanding: 4,674,495
• 10 Day Avg. Volume: 1,275
• 30 Day Avg. Volume: 1,275
• PEG Ratio: <0.01
• Price to Book (P/B): 0.04
• Price to Sales (P/S): 0.02
• P/FCF Ratio: -0.12
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 41 Neutral
• Price Target: ―

Applied UV's stock score is heavily impacted by significant financial performance challenges, primarily driven by profitability and cash flow issues. The lack of technical analysis data and valuation metrics further weighs down the score. Absence of earnings call insights or corporate events leaves little room for optimism about short-term performance improvements.

Applied UV Business Overview & Revenue Model

Company Description

Applied UV, Inc., through its subsidiaries, develops, acquires, and commercializes technology that addresses air purification and infection control in the healthcare, hospitality, commercial, municipal, and residential markets in the United States, Canada, and Europe. It operates through Disinfection and Hospitality segments. The company offers science-based solutions and products in air purification under the Airocide brand; and disinfection of hard surfaces under the Lumicide brand. It also manufactures and supplies fine decorative framed mirrors, framed arts, and bathroom vanities. The company was incorporated in 2019 and is headquartered in Mount Vernon, New York.

How the Company Makes Money

Applied UV generates revenue primarily through the sale of its UV disinfection systems and related services. The company's key revenue streams include direct sales to healthcare facilities, hotels, food processing plants, and other commercial entities looking to enhance their sanitation protocols. Additionally, Applied UV may establish partnerships with distributors and service providers to expand its market reach. The company may also earn income from maintenance and support services associated with its products, as well as potential licensing agreements for its patented technology.

Applied UV Financial Statement Overview

Summary

Applied UV demonstrates strong revenue growth yet faces significant profitability challenges. The balance sheet is moderately leveraged but shows signs of increased financial risk due to growing liabilities. Cash flow remains a critical issue, underlined by negative operating and free cash flows. The company needs to enhance profitability and cash management to achieve financial stability.

Income Statement

Applied UV has shown significant revenue growth over the years, particularly noticeable from 2022 to 2023. However, the company struggles with negative net income and EBIT margins, indicating a challenge in profitability despite increased sales. The gross profit margin remains positive but low, suggesting cost management issues.

Balance Sheet

The balance sheet shows a moderate debt-to-equity ratio indicating a balanced leverage position. However, a declining equity ratio suggests increased liabilities over equity, which might pose financial stability risks. The return on equity is negative due to consistent net losses, highlighting profitability concerns.

Cash Flow

The company's cash flow statement reflects negative operating cash flow and free cash flow, indicating cash generation issues. Although financing activities provided a cash influx, heavy reliance on external financing raises sustainability concerns. The free cash flow to net income ratio is negative, reflecting operational inefficiencies.

Breakdown	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
Income Statement
Total Revenue	40.72M	20.14M	11.67M	5.73M	9.33M
Gross Profit	7.83M	4.04M	4.10M	1.01M	3.32M
EBITDA	-9.05M	-8.87M	-5.71M	-3.30M	1.41M
Net Income	-13.20M	-22.05M	-7.39M	-3.37M	2.80M
Balance Sheet
Total Assets	58.39M	32.73M	38.53M	13.12M	4.77M
Cash, Cash Equivalents and Short-Term Investments	1.13M	2.73M	7.92M	11.76M	1.03M
Total Debt	8.21M	7.77M	1.90M	950.64K	793.61K
Total Liabilities	33.50M	15.49M	5.86M	3.36M	3.38M
Stockholders Equity	24.88M	17.23M	32.67M	9.75M	1.38M
Cash Flow
Free Cash Flow	-8.78M	-8.76M	-7.03M	-875.86K	757.26K
Operating Cash Flow	-8.22M	-8.74M	-7.00M	-657.23K	770.26K
Investing Cash Flow	-4.84M	-176.28K	-14.59M	-218.63K	-13.00K
Financing Cash Flow	11.46M	2.88M	18.60M	11.60M	-521.09K

Applied UV Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
HBB	69 Neutral	$200.54M	6.32	20.79%	3.16%	-2.09%	-5.04%
Sector *	61 Neutral	$18.38B	12.79	-2.54%	3.03%	1.52%	-15.83%
VIOT	49 Neutral	$235.76M	26.86	5.61%	2.16%	-8.42%	―
LCUT	48 Neutral	$88.82M	―	-17.08%	4.34%	-1.14%	-95.76%
ATER	46 Neutral	$11.78M	―	-42.87%	―	-28.98%	53.51%
AUVI	41 Neutral	$467.00	―	―	―	―	―